Delivery Order SPE2DB24D1104-SPE2DB25FYEU4
- Not listed
- The Defense Logistics Agency awarded a $1,837.56 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a completion deadline of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The award carries no set-aside designation, indicating it was competitively awarded. Performance will occur at the vendor's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Nucynta ER (tapentadol extended-release) 100mg tablets, valued at $6,005.43. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by August 5, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $1,225.04 and an ultimate completion date of August 6, 2025. The award represents a non-competitive action under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency Medical Supply Chain awarded a $4,442.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nucynta (tapentadol) 50mg tablets. This non-set-aside delivery order, with an ultimate completion date of August 12, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units, with a ceiling value of $1,225.04. This firm fixed-price delivery order is scheduled for completion by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $3,816.36 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 100 mg tablets in quantities of 100 units. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the award from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,788.38 to AmerisourceBergen Drug Corp for Nucynta 100 mg tablets (100 count) on August 20, 2025, with completion scheduled for August 21, 2025. This competitive award, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract employs firm fixed price pricing and represents a relatively small-value transaction within the pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Nucynta ER 100 mg tablets (60-count packages) valued at $1,975.65. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in a quantity of 100 units under a firm fixed-price contract with a ceiling value of $1,225.04. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive, non-set-aside procurement. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $2,004.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Nucynta ER 100 mg tablets (60-count). This contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order was competitively awarded with no set-aside designation and is scheduled for completion by...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYEU4Delivery Order
The Defense Logistics Agency awarded a $2,862.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta (tapentadol) 100 mg tablets in a 100-count package. This competitively awarded, non-set-aside contract will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. The delivery order represents a child contract action under AmerisourceBergen Drug Corp's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a comprehensive $999.999 billion indefinite delivery contract (SPE2DX) with DLA Troop Support Medical extending through December 2026. This prime vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military and federal healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Nucynta, an opioid pain management pharmaceutical, exemplifies the company's role as a critical vendor within the federal medical supply chain, fulfilling individual therapeutic requirements through the DLA's pharmaceutical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/20/25 |